Skip to content
value.today

Dnanexus, Inc.

🇺🇸 Palo Alto, California, USABiotechnologyFounded 2009
Total raised
$32 M
3 rounds on record
Latest round
$15 M
Apr 2015
First round on record
May 2009
Today
Private
No later event on record

Funding rounds

3 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Dnanexus, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Apr 2015$15 MNo. 3$10 to $50 million

Dnanexus, Inc.: Raise no. 3, Apr 2015

Investors in this round

1 investor had bought by the notice of Apr 23, 2015: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$15 M of $15 M offered
Smallest investment taken
no minimum stated
What was sold
equity, debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Richard Daly · Executive Officer, Director
  • Stephen Thau · Executive Officer
  • Geoff Duyk · Director
  • Hannes Smarason · Director
  • Krishna Yeshwant · Director
  • Michael Goldberg · Director
  • Nathaniel Goldhaber · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Stephen Thau, Secretary. Source: SEC Form D, newest notice filed Apr 23, 2015. Read the notice at the SEC.

equity, debt, optionsSEC
Dec 2013$15 MNo. 2$10 to $50 million

Dnanexus, Inc.: Raise no. 2, Dec 2013

Investors in this round

4 investors had bought by the notice of Jan 3, 2014: 4 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$15 M of $15 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Andreas Sundquist · Executive Officer, Director
  • Richard Daly · Executive Officer, Director
  • Geoff Duyk · Director
  • Krishna Yeshwant · Director
  • Michael Goldberg · Director
  • Nathaniel Goldhaber · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Richard Daly, Chief Executive Officer. Source: SEC Form D, newest notice filed Jan 3, 2014. Read the notice at the SEC.

equitySEC
May 2009$2 MNo. 1Under $2 million

Dnanexus, Inc.: Raise no. 1, May 2009

Investors in this round

10 investors had bought by the notice of Jul 30, 2009: 10 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $2 M offered; $0 M still to sell
Smallest investment taken
$24,999
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
No revenue
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Andreas Sundquist · Executive Officer, Director, Promoter
  • Rob Hayes · Director
  • Serafim Batzoglou · Director, Promoter
  • Arend Sidow · Promoter

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Andreas Sundquist, President. Source: SEC Form D, newest notice filed Jul 30, 2009. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Dnanexus, Inc. chose not to state its revenue in its newest notice of a funding round (Apr 2015).

    SEC Form D · Apr 2015

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Apr 2015

That is all the official record says: Dnanexus, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Dnanexus, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 10 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Dnanexus, Inc.
NameRoleNamed in
Richard DalyExecutive officerApr 2015
Stephen ThauExecutive officerApr 2015
Andreas SundquistExecutive officerJan 2014
Geoff DuykDirectorApr 2015
Hannes SmarasonDirectorApr 2015
Krishna YeshwantDirectorApr 2015
Michael GoldbergDirectorApr 2015
Nathaniel GoldhaberDirectorApr 2015
Richard DalyDirectorApr 2015
Andreas SundquistDirectorJan 2014
Rob HayesDirectorJul 2009
Serafim BatzoglouDirectorJul 2009
Andreas SundquistPromoterJul 2009
Arend SidowPromoterJul 2009
Serafim BatzoglouPromoterJul 2009